Phase
Condition
Vaginitis
Vaginal Atrophy
Treatment
N/AClinical Study ID
Ages 45-70 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Menopausal participants for at least 6 months;
Participants with complaints of vaginal dryness;
Skin integrity in the region of product analysis;
Agreement to comply the procedures of the trial and attend the clinic on the days andtimes determined for applications and / or evaluations;
Understanding, agreement and signing of the Informed Consent Term.
Exclusion
Exclusion Criteria:
Use of anti-inflammatory / immunosuppressive / antihistamine drugs up to 3 weeks priorto selection;
Pathologies and / or active skin lesions (local and / or disseminated) in theevaluation area;
Immunosuppression by drugs or active diseases;
Decompensated endocrinopathies;
Relevant clinical history or current evidence of alcohol or other drug abuse;
known history or suspected intolerance to products of the same category;
Intense sun exposure up to 15 days before evaluation;
Gynecological treatment up to 4 weeks before evaluation;
Other conditions considered by the researcher to be reasonable for disqualification ofstudy participation.